SCHEMBL12075409

SCHEMBL12075409

COc1cc2nccc(Cc3ccc(Nc4ncccc4C(=O)NCc4cccc(Cl)c4)cc3)c2cc1OC

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ POLB P06746 2/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ KDR P35968 8/20 0.46
▸ PDE10A Q9Y233 1/20 0.46
▸ EGFR P00533 2/20 0.45
▸ RAF1 P04049 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ APEX1 P27695 1/20 0.44
▸ HCRTR1 O43613 1/20 0.44
▸ HCRTR2 O43614 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ RET P07949 1/20 0.44
▸ PDGFRA P16234 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12074825 0.93 MAPT (0.54) MAPTMEN1KMT2APOLBALDH1A1
SCHEMBL12075204 0.91 MAPT (0.53) MAPTMEN1KMT2APOLBALDH1A1
SCHEMBL12075408 0.91 MAPT (0.52) MAPTMEN1KMT2APOLBALDH1A1
SCHEMBL12074829 0.89 MAPT (0.54) MAPTMEN1KMT2APOLBALDH1A1
SCHEMBL14148253 0.89 MAPT (0.55) MAPTMEN1KMT2APOLBALDH1A1
SCHEMBL14148280 0.89 MAPT (0.55) MAPTMEN1KMT2APOLBALDH1A1
SCHEMBL12074827 0.88 MAPT (0.51) MAPTMEN1KMT2APOLBALDH1A1
SCHEMBL12075210 0.88 MAPT (0.54) MAPTMEN1KMT2APOLBALDH1A1
SCHEMBL14148236 0.88 NUDT1 (0.50) MAPTMEN1KMT2APOLBALDH1A1
SCHEMBL1474621 0.88 KDR (0.58) MAPTMEN1KMT2APOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125780-B1 SUBSTITUTED HETEROCYCLES AND METHODS OF USE AMGEN INC (US) 2012-08-29 — — EP disclosed
WO-2008079294-A1 SUBSTITUTED HETEROCYCLES AND METHODS OF USE AMGEN INC. (US) 2008-07-03 — — WO disclosed
Send feedback